T he accurate classification of the primary site and histology of reportable malignancies by cancer registrars requires careful review of the medical records, especially pathology and surgery reports. The pathologic distinction between cancer of the ovary and cancer of extraovarian tissue can be dif
Multiple primary cancers of the ovary in the United States, 1992–1997
✍ Scribed by Holly L. Howe; Rachel Weinstein; Joellyn Hotes; Betsy Kohler; Steven D. Roffers; Marc T. Goodman
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 142 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
T he North American Association of Central Cancer Registries (NAACCR), formerly the American Association of Central Cancer Registries, was formed in 1987 to create registration standards and to provide a forum for the promotion and advancement of registry activities. The NAACCR's activities have gro
R%: relative percentage. a Malignant ovarian tumors exclude serous cystadenoma (8442), papillary cystadenoma (8451), papillary serous cystadenoma (8462), mucinous cystadenoma (8472), and papillary mucinous cystadenoma (8473). b Rates are per 100,000 and are age-adjusted to the 1970 United States sta
A n estimated 13,900 women in the U.S. were expected to die from ovarian cancer in 2001, 1 making it the most fatal malignancy of the female genital tract. 2 Ovarian cancer also is the fifth leading cause of cancer deaths among women. 3 Although these statistics are alarming, to our knowledge only a